Skip to content

The verification study for improving the blood flow: A randomized double-blind placebo-controlled trial

The verification study for improving the blood flow: A randomized double-blind placebo-controlled trial - The verification study for improving the blood flow

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028182
Enrollment
40
Registered
2017-07-11
Start date
2017-07-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese adults

Interventions

Duration: 4 weeks Test materials: Wild herb fermented liquid Administration: Drink a cup of the beverage with a dosing cup (25 mL), once a day at optional timing * Daily dose must be taken within t

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Seishin-kai Medical Association Inc, Takara Medical Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese adults 2. Those who are anxious about the results of the recent medical checkup (the values of HbA1c and blood pressure are rather high) 3. Those who are considered as appropriate for the study by the physician 4. Those whose blood fluidity score (smoothness) is "2: caution" or "3: unusual" at screening and examination before ingestion 5. Among the people who passed 4., select those whose blood flow velocity is relatively slow at screening and examination before ingestion

Exclusion criteria

Exclusion criteria: 1. At least one previous medical history or under the treatment of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, or other chronic diseases 3. Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily 4. Currently taking medicines (include herbal medicines) and supplements 5. Those who are allergic to medicines and/or the test food related products 6. Those who have terrible anemia (including currently under the treatment of anemia) 7. Those who drink alcoholic beverages to excess {Average amount of alcohol intake is approximately 60 g per day converted into absolute alcohol (approximately 540 mL of Japanese sake, 3 cans (500 mL / can) of beer, or 300 mL of distilled spirits) } 8. Those who habitually apply medicines to their hands (except for external medicine, moisturizer, and sunscreen) 9. Smokers 10. Those who are chipping off the cuticle on fingernails 11. Those who are pregnant, breast-feeding, and plan to become a pregnant 12. Those who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial 13. Others considered as inappropriate for the study by the physician

Design outcomes

Primary

MeasureTime frame
Blood flow inspection 1. Blood fluidity (MC-FAN) 2. Conditions of the capillaries (Bscan-Z) *1,2 Assess at 0 and 4 weeks after consuming

Secondary

MeasureTime frame
Questionnaire of subjective symptoms (The Likert scale method) * Assess at 0 and 4 weeks after consuming

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026